Understanding the True Costs of ADHD: An Examination of the Whole-Life Impact


Ann Childress, MD
President, Center for Psychiatry and Behavioral Medicine, Inc.
Associate Professor Child/Adolescent Psychiatry
Touro University Nevada College of Osteopathic Medicine, Henderson, NV
Clinical Associate Professor, University of Nevada, Las Vegas School of Medicine, Las Vegas, NV
Ann Childress, MD

Before earning her medical degree at the Medical University of South Carolina, Charleston, Dr. Childress studied at St. Louis University School of Medicine, St. Louis, Missouri. She completed a psychiatry internship and residency as well as a fellowship in child and adolescent psychiatry at the Medical University of South Carolina in Charleston, South Carolina.

Today, roughly 80% of her practice is research-based. She also has adjunct faculty appointments at the University of Nevada Las Vegas School of Medicine and Touro University Nevada College of Osteopathic Medicine. Dr. Childress is board certified in psychiatry, with a subspecialty in child and adolescent psychiatry.Dr. Childress has authored numerous publications on the topic of ADHD. As Co-Principal Investigator, she has participated in more than 175 clinical trials.

Dr. Childress is also a distinguished fellow of the American Psychiatric Association and a member of the American Academy of Child and Adolescent Psychiatry. She is President of The American Professional Society of ADHD and Related Disorders, and is Education Director for the Nevada Psychiatric Association.

Thomas E. Brown, PhD
Director, Brown Clinic for Attention & Related Disorders, Manhattan Beach, CA
Clinical Professor of Psychiatry and Neuroscience, University of California, Riverside School of Medicine, Riverside, CA
Thomas E. Brown, PhD

Thomas E. Brown earned his PhD in Clinical Psychology at Yale University and then served on the clinical faculty of the Department of Psychiatry at Yale School of Medicine for 20 years while operating a clinic in Connecticut for children and adults with ADHD and related problems. In May 2017 he relocated to California where he opened his Brown Clinic for Attention and Related Disorders in Manhattan Beach, California. He has taught continuing medical education courses on ADHD for the American Psychiatric Association for the past 25 years and has given lectures and workshops in hospitals, medical schools, universities and for professional and advocacy groups throughout the United States and in more than 40 other countries.

Dr. Brown served as Adjunct Clinical Associate Professor of Psychiatry & Behavioral Sciences at the Keck School of Medicine of the University of Southern California and is an elected Fellow of the American Psychological Association and the Society of Clinical Child & Adolescent Psychology. He has published 30 articles in professional journals and 5 books on ADHD. His most recent books are Smart, but Stuck: Emotions in Teens and Adults with ADHD; Outside the Box: Rethinking ADD/ADHD in Children and Adults-A Practical Guide, and ADHD and Asperger Syndrome in Smart Kids and Adults: Twelve Stories of Struggle, Support and Treatment. His website is www.BrownADHDClinic.com.

Statement of Need

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that can persist into adulthood, with a course that impacts brain morphology, cognitive and psychosocial functioning, and psychiatric and medical comorbidities. Subsequently, ADHD is associated with an increased risk of morbidity and mortality. It is imperative to acknowledge the whole-being impact of ADHD as well as the variable consequences of this disorder as the individual transitions from childhood to adulthood. This increased awareness should not only facilitate a better understanding of the seriousness of the condition but also provide an impetus to seek and implement treatment.

The first installment of this 4-part CME Outfitters series on ADHD will feature a discussion by Drs. Ann Childress and Thomas E. Brown on the extensive burden and impact of ADHD in children and adults. Additionally, the activity will include the use of a 3-D model highlighting the various systems and domains impacted.

Learning Objectives

At the end of this CME/CE activity, participants should be able to identify the extensive burden imposed by ADHD, including brain morphology, cognitive and psychosocial functioning, and psychiatric and medical comorbidities.

Financial Support

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Target Audience

Physicians, PAs, nurse practitioners, nurses, and pharmacists specializing in psychiatry, primary care, and/or pediatrics.

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 1.0

This activity is designated for 1.0 contact hour.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

PAs (AAPA) 1.0

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until the expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Childress reports the following financial relationships: Consultant: : Aardvark Therapeutics, Inc.; Corium Inc.; Jazz Pharmaceuticals, Inc.; KemPharm, Inc.; Lumos Pharma; Neos Therapeutics, Inc.; Noven Pharmaceuticals, Inc.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; and Tulex Pharmaceuticals. Research Support: : Adlon Therapeutics L.P.; Akili Interactive Labs, Inc.; Allergan; Arbor Pharmaceuticals; KemPharm, Inc.; Neos Therapeutics, Inc.; Otsuka America Pharmaceutical, Inc.; Purdue Pharma L.P.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Takeda Pharmaceuticals U.S.A., Inc.; and Tris Pharma, Inc. Speakers Bureau: Corium Inc.; Ironshore Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Takeda Pharmaceuticals U.S.A., Inc.; and Tris Pharma, Inc. Other Financial or Material Support: Writing support for Purdue Pharma L.P.; Supernus Pharmaceuticals, Inc.; and Takeda Pharmaceuticals U.S.A., Inc.

Dr. Brown reports the following Financial or Material Support: Royalties for publications from American Psychiatric Publishing; Jossey-Bass/John Wiley; Routledge; and Yale University Press

Disclosures were obtained from the CME Outfitters, LLC, staff: No disclosures to report.

  • Michael Franks, APRN, AGACNP-BC, FNP-BC (peer reviewer)
  • Meghann Taft-Lockard (planning committee)
  • Kashemi D. Rorie, PhD (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Additional Formats

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).


Understanding the True Costs of ADHD: An Examination of the Whole-Life Impact
Event Date: 05/25/2022